Lilly confirms date and conference call for third-quarter 2025 financial results announcement
Rhea-AI Summary
Eli Lilly (NYSE: LLY) will release its third-quarter 2025 financial results on October 30, 2025.
The company will host a conference call for investors and media on the same day beginning at 10:00 a.m. Eastern time, with a live webcast and a replay available via the investor website at https://investor.lilly.com/webcasts-and-presentations.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, LLY declined 0.87%, reflecting a mild negative market reaction. Our momentum scanner triggered 12 alerts that day, indicating notable trading interest and price volatility. This price movement removed approximately $6.81B from the company's valuation, bringing the market cap to $775.51B at that time.
Data tracked by StockTitan Argus on the day of publication.
The conference call will begin at 10 a.m. Eastern time. Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on Lilly's website at https://investor.lilly.com/webcasts-and-presentations. A replay will also be available on the website following the conference call.
About Lilly
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news, or follow us on Facebook, Instagram, and LinkedIn. F-LLY
Trademarks and Trade Names
All trademarks or trade names referred to in this press release are the property of the company, or, to the extent trademarks or trade names belonging to other companies are references in this press release, the property of their respective owners. Solely for convenience, the trademarks and trade names in this press release are referred to without the ® and ™ symbols, but such references should not be construed as any indicator that the company or, to the extent applicable, their respective owners will not assert, to the fullest extent under applicable law, the company's or their rights thereto. We do not intend the use or display of other companies' trademarks and trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies.
|
Refer to: |
Ashley Hennessey; gentry_ashley_jo@lilly.com; 317-416-4363 (Media) |
|
|
Michael Czapar; czapar_michael_c@lilly.com; 317-617-0983 (Investors) |
View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-confirms-date-and-conference-call-for-third-quarter-2025-financial-results-announcement-302585549.html
SOURCE Eli Lilly and Company
FAQ
When will Eli Lilly (LLY) report Q3 2025 results?
What time is the Eli Lilly (LLY) Q3 2025 conference call?
How can investors join the Eli Lilly (LLY) Q3 2025 webcast?
Will there be a replay of the Eli Lilly (LLY) Q3 2025 conference call?
Who is the audience for the Eli Lilly (LLY) October 30, 2025 call?
